Terms: = Pancreatic cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1
17 results:
1. Asperulosidic Acid Restrains Hepatocellular Carcinoma Development and Enhances Chemosensitivity Through Inactivating the mekk1/NF-κB Pathway.
Li L; Qiu H
Appl Biochem Biotechnol; 2024 Jan; 196(1):1-17. PubMed ID: 37097403
[TBL] [Abstract] [Full Text] [Related]
2. Small-molecule IKKβ activation modulator (IKAM) targets map3k1 and inhibits pancreatic tumor growth.
Napoleon JV; Sagar S; Kubica SP; Boghean L; Kour S; King HM; Sonawane YA; Crawford AJ; Gautam N; Kizhake S; Bialk PA; Kmiec E; Mallareddy JR; Patil PP; Rana S; Singh S; Prahlad J; Grandgenett PM; Borgstahl GEO; Ghosal G; Alnouti Y; Hollingsworth MA; Radhakrishnan P; Natarajan A
Proc Natl Acad Sci U S A; 2022 May; 119(18):e2115071119. PubMed ID: 35476515
[TBL] [Abstract] [Full Text] [Related]
3. Treatment outcomes of erlotinib plus gemcitabine as late-line chemotherapy in unresectable pancreatic cancer.
Mie T; Sasaki T; Takeda T; Okamoto T; Mori C; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
Jpn J Clin Oncol; 2021 Aug; 51(9):1416-1422. PubMed ID: 34128055
[TBL] [Abstract] [Full Text] [Related]
4. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Ma H; Song B; Guo S; Li G; Jin G
Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
[TBL] [Abstract] [Full Text] [Related]
5. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.
Yamada A; Komaki Y; Komaki F; Micic D; Zullow S; Sakuraba A
Lancet Oncol; 2018 Jun; 19(6):758-767. PubMed ID: 29706374
[TBL] [Abstract] [Full Text] [Related]
6. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project.
Mochamat ; Cuhls H; Marinova M; Kaasa S; Stieber C; Conrad R; Radbruch L; Mücke M
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):25-39. PubMed ID: 27897391
[TBL] [Abstract] [Full Text] [Related]
7. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
[TBL] [Abstract] [Full Text] [Related]
8. Depleting mekk1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.
Su F; Li H; Yan C; Jia B; Zhang Y; Chen X
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1655-63. PubMed ID: 19513748
[TBL] [Abstract] [Full Text] [Related]
9. The MAPK kinase kinase-1 is essential for stress-induced pancreatic islet cell death.
Mokhtari D; Myers JW; Welsh N
Endocrinology; 2008 Jun; 149(6):3046-53. PubMed ID: 18308848
[TBL] [Abstract] [Full Text] [Related]
10. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.
Shankar S; Suthakar G; Srivastava RK
Front Biosci; 2007 Sep; 12():5039-51. PubMed ID: 17569628
[TBL] [Abstract] [Full Text] [Related]
11. The antitumor efficacy of calcitriol: preclinical studies.
Johnson CS; Muindi JR; Hershberger PA; Trump DL
Anticancer Res; 2006; 26(4A):2543-9. PubMed ID: 16886662
[TBL] [Abstract] [Full Text] [Related]
12. Development of an enzyme-linked immunosorbent assay (ELISA) for the specific detection of mekk1 expression in cells.
Ding Y; Huang D; Chen XG
J Pharmacol Toxicol Methods; 2005; 51(2):159-67. PubMed ID: 15767210
[TBL] [Abstract] [Full Text] [Related]
13. Survival regulation in pancreatic cancer cells by c-Jun.
Okutomi Y; Shino Y; Komoda F; Hirano T; Ishihara T; Yamaguchi T; Saisho H; Shirasawa H
Int J Oncol; 2003 Oct; 23(4):1127-34. PubMed ID: 12963995
[TBL] [Abstract] [Full Text] [Related]
14. Dominant negative mekk1 inhibits survival of pancreatic cancer cells.
Hirano T; Shino Y; Saito T; Komoda F; Okutomi Y; Takeda A; Ishihara T; Yamaguchi T; Saisho H; Shirasawa H
Oncogene; 2002 Aug; 21(38):5923-8. PubMed ID: 12185592
[TBL] [Abstract] [Full Text] [Related]
15. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes.
Waeber G; Delplanque J; Bonny C; Mooser V; Steinmann M; Widmann C; Maillard A; Miklossy J; Dina C; Hani EH; Vionnet N; Nicod P; Boutin P; Froguel P
Nat Genet; 2000 Mar; 24(3):291-5. PubMed ID: 10700186
[TBL] [Abstract] [Full Text] [Related]
16. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract] [Full Text] [Related]
17. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
[TBL] [Abstract] [Full Text] [Related]
